Drug Industry Trade Groups File Lawsuits on Most-Favored-Nation Pricing Rule
The Trump administration recently announced an interim final rule to implement the Most Favored Nation drug pricing model, which would tie prices of certain Medicare Part B drugs to the lowest prices paid in Organisation for Economic Cooperation and Development (OECD) countries. In response, drug industry trade groups have filed two lawsuits against the administration on December […]